Vice President of Finance Severance AgreementPresident of Finance Severance Agreement • March 23rd, 2017 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledMarch 23rd, 2017 Company Industry JurisdictionThis Vice President of Finance Severance Agreement (the “Agreement”) is entered into as of July 7, 2015 (the “Effective Date”) by and between Charles N. York II (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).